Effectiveness of Different Types of Training in Older Adults With Sarcopenic Obesity
Launched by UNIVERSITY OF SALAMANCA · Mar 24, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Design: This study is a randomized controlled clinical trial with three parallel groups, recruiting women over 65 years old with sarcopenic obesity. Participants will be randomly assigned to one of three intervention groups. The study will span 8 months, with two assessment points: an initial evaluation and a final follow-up at 8 months. Throughout the intervention period, participants will attend three supervised sessions per week, each lasting 50 minutes.
Setting: The study will take place in the Salamanca Health Area, in collaboration with the Research, Teaching, and Care Unit of the Fa...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women older than 65 years.
- • Diagnosis of sarcopenic obesity (SMI \< 5.5 kg/m2, BMI \> 30 kg/m2)
- Exclusion Criteria:
- • Tumors
- • Pacemakers
- • Fibrillations
- • Cardiac pathology or uncontrolled hypertension
- • History of severe trauma/recent cervical surgery
- • Uncontrolled systemic and inflammatory pathologies
- • Congenital collagen compromise
- • Presence of difficulties in performing the Initial Evaluation tests
- • Language barriers
- • Pending litigation or legal claim
About University Of Salamanca
The University of Salamanca, one of the oldest and most prestigious universities in Spain, is a leading institution in academic research and clinical trials. With a strong commitment to advancing healthcare and medical science, the university engages in innovative research initiatives that address critical health challenges. Its clinical trial programs are characterized by rigorous scientific methodology, interdisciplinary collaboration, and a focus on ethical standards, ensuring high-quality outcomes that contribute to the advancement of medical knowledge and patient care. The University of Salamanca fosters partnerships with healthcare professionals and industry leaders, positioning itself at the forefront of clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salamanca, , Spain
Patients applied
Trial Officials
Roberto Méndez Sánchez, PhD
Principal Investigator
University of Salamanca
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported